Dual cell seeding and the use of zymogen tissue plasminogen activator to improve cell retention on polytetrafluoroethylene grafts

Journal of Vascular Surgery

Volumn 34, Issue 2, 2001, Pages 337-343

  Yu, Hong ^a,c   Wang, Ying ^a   Eton, Darwin ^b   Rowe, Vincent L ^a   Terramani, Thomas T ^a   Cramer, Donald V ^a   Starnes, Vaughn A ^a   Weaver, Fred A ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME PRECURSOR; PLASMINOGEN ACTIVATOR; POLITEF; TISSUE PLASMINOGEN ACTIVATOR;

ARTICLE; BLOOD VESSEL PROSTHESIS; CELL ADHESION; CELL COUNT; CELL CULTURE; CYTOLOGY; PROSTHESIS; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

BLOOD VESSEL PROSTHESIS; CELL ADHESION; CELL COUNT; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; ENZYME PRECURSORS; MUSCLE, SMOOTH, VASCULAR; PLASMINOGEN ACTIVATORS; POLYTETRAFLUOROETHYLENE; PROSTHESIS DESIGN; TISSUE PLASMINOGEN ACTIVATOR;

EID: 0035430735     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1067/mva.2001.114817     Document Type: Article

References (35)

1. Herring M, Gardner A, Glover J. A single-staged technique for seeding vascular grafts with autogenous endothelium. Surgery 1978; 84:498-504.
2. Eickhoff JH, Broome A, Ericsson BF, Buchardt Hansen HJ, Kordt KF, Mouritzen C, et al. Four years' results of a prospective, randomized clinical trial comparing polytetrafluoroethylene and modified human umbilical vein for below-knee femoropopliteal bypass. J Vasc Surg 1987;6:506-11.
3. Deutsch M, Meinhart J, Fischlein T, Preiss P, Zilla P. Clinical autologous in vitro endothelialization of infrainguinal ePTFE grafts in 100 patients: a 9-year experience. Surgery 1999;126:847-55.
4. Jensen N, Lindblad B, Bergqvist D. Endothelial cell seeded dacron aortobifurcated grafts: platelet deposition and long-term follow-up. J Cardiovasc Surg 1994;35:425-9.
5. Kaehler J, Zilla P, Fasol R, Deutsch M, Kadletz M. Precoating substrate and surface configuration determine adherence and spreading of seeded endothelial cells on polytetrafluoroethylene grafts. J Vasc Surg 1989;9:535-41.
6. Falk J, Townsend LE, Vogel M, Boyer M, Olt S, Wease GL, et al. Improved adherence of genetically modified endothelial cells to smalldiameter expended polytetrafluoroethylene grafts in a canine model. J Vasc Surg 1998;27:902-9.
7. Clowes MM, Lynch CM, Miller AD, Miller DG, Osborne WR, Clowes AW. Long-term biological response of injured rat carotid artery seeded with smooth muscle cells expressing retrovirally introduced human genes. J Clin Invest 1994;93:644-51.
8. Geary RL, Clowes AW, Lau S, Vergel S, Dale DC, Osborne WR. Gene transfer in baboons using prosthetic vascular grafts seeded with retrovirally transduced smooth muscle cells: a model for local and systemic gene therapy. Hum Gene Ther 1994;5:1211-6.
9. Shayani V, Newman KD, Dichek DA. Optimization of recombinant tPA secretion from seeded vascular grafts. J Surg Res 1994;57:495-504.
10. Ekhterae D, Stanley JC. Retroviral vector-mediated transfer and expression of human tissue plasminogen activator gene in human endothelial and vascular smooth muscle cells. J Vasc Surg 1995;21: 953-62.
11. Boose JA, Kuismanen E, Gerard R, Sambrook J, Gething MJ. The single-chain form of tissue-type plasminogen activator has catalytic activity: studies with a mutant enzyme that lacks the cleavage site. Biochemistry 1989;28:635-43.
12. Huber TS, Welling TH, Sarkar R, Messina LM, Stanley JC. Effects of retroviral-mediated tissue plasminogen activator gene transfer and expression on adherence and proliferation of canine endothelial cells seeded onto expanded polytetrafluoroethylene. J Vasc Surg 1995;22: 795-803.
13. Dunn PF, Newman KD, Jones M, Yamada I, Shayani V, Virmani R, et al. Seeding of vascular grafts with genetically modified endothelial cells. Secretion of recombinant tPA results in decreased seeded cell retention in vitro and in vivo. Circulation 1996;93:1439-46.
14. Tachias K, Madison EL. Variants of tissue-type plasminogen activator which display substantially enhanced stimulation by fibrin. J Biol Chem 1995;270:18319-22.
15. DuBridge RB, Tang P, Hsia HC, Leong PM, Miller JH, Calos MP. Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system. Mol Cell Biol 1987;7:379-87.
16. Ory DS, Neugeboren BA, Mulligan RC. A stable human-derived packaging cell line for production of high titer retro virus/vesicular stomatitis virus G pseudotypes. Proc Natl Acad Sci U S A 1996;93: 11400-6.
17. Eton D, Terramani TT, Wang Y, Takahashi AM, Nigro JJ, Tang L, et al. Genetic engineering of stent grafts with a highly efficient pseudotyped retroviral vector. J Vasc Surg 1999;29:863-73.
18. Terramani TT, Eton D, Bui PA, Wang Y, Weaver FA, Yu H. Human macrovascular endothelial cells: optimization of culture conditions. In Vitro Cell Dev Biol Anim 2000;36:125-32.
19. Kwon YJ, Yu H, Peng CA. Enhanced retroviral transduction of 293 cells cultured on liquid-liquid interfaces. Biotechnol Bioeng 2001;72:331-8.
20. Yu H, Eton D, Wang Y, Kumar S, Tang L, Terramani T, et al. High efficiency in vitro gene transfer into vascular tissues using a pseudotyped retroviral vector without pseudotransduction. Gene Ther 1999; 6:1876-83.
21. Yu H, Wang Y, Eton D, Stins M, Wang L, Apuzzo ML, et al. Retroviral vector-mediated transfer and expression of human tissue plasminogen activator cDNA in bovine brain endothelial cells. Neurosurgery 1999;45:962-968; discussion 968-970.
22. Dewey CF Jr. Fluid mechanics of arterial flow. In: Werthessen NT, WolfS, editors. Dynamics of arterial flow. New York: Plenum; 1979. p. 55-103.
23. Kesler KA, Herring MB, Arnold MP, Glover JL, Park HM, Helmus MN, et al. Enhanced strength of endothelial attachment on polyester elastomer and polytetrafluoroethylene graft surfaces with fibronectin substrate. J Vasc Surg 1986;3:58-64.
24. Bhat VD, Truskey GA, Reichert WM. Fibronectin and avidin-biotin as a heterogeneous ligand system for enhanced endothelial cell adhesion. J Biomed Mater Res 1998;41:377-85.
25. Massia SP, Hubbell JA. Vascular endothelial cell adhesion and spreading promoted by the peptide REDV of the IIICS region of plasma fibronectin is mediated by integrin alpha 4 beta 1. J Biol Chem 1992;267:14019-26.
26. Pratt KJ, Williams SK, Jarrell BE. Enhanced adherence of human adult endothelial cells to plasma discharge modified polyethylene terephthalate. J Biomed Mater Res 1989;23:1131-47.
27. Glukhova MA, Koteliansky VE. Integrins, cytoskeletal and extracellular matrix proteins in developing smooth muscle cells of human aorta. In: Schwartz SM, Mecham RP, editors. The vascular smooth muscle cell. San Diego: Academic Press; 1995. p. 17-36.
28. Ono O, Ando J, Kamiya A, Kuboki Y, Yasuda H. Flow effects on cultured vascular endothelial and smooth muscle cell functions. Cell Struct Funct 1991;16:365-74.
29. Fillinger MF, O'Connor SE, Wagner RJ, Cronenwett JL. The effect of endothelial cell coculture on smooth muscle cell proliferation. J Vasc Surg 1993;17:1058-67; discussion 1067-8.
30. Powell RJ, Cronenwett JL, Fillinger MF, Wagner RJ, Sampson LN. Endothelial cell modulation of smooth muscle cell morphology and organizational growth pattern. Ann Vasc Surg 1996;10:4-10.
31. Schwartz SM, R. OBE, Deblois D, Giachelli CM. Relevance of smooth muscle replication and development to vascular disease. In: Schwartz SM, Mecham RP, editors. The vascular smooth muscle cell. San Diego: Academic Press; 1995. p. 81-121.
32. Garg UC, Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 1989;83:1774-7.
33. Kariya K, Kawahara Y, Araki S, Fukuzaki H, Takai Y. Antiproliferative action of cyclic GMP-elevating vasodilators in cultured rabbit aortic smooth muscle cells. Atherosclerosis 1989;80:143-7.
34. von der Leyen HE, Gibbons GH, Morishita R, Lewis NP, Z-hang L, Nakajima M, et al. Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene. Proc Natl Acad Sci U S A 1995;92:1137-41.
35. Chen L, Daum G, Forough R, Clowes M, Walter U, Clowes AW. Overexpression of human endothelial nitric oxide synthase in rat vascular smooth muscle cells and in balloon-injured carotid artery. Circ Res 1998;82:862-70.